Medpace Holdings (MEDP) - Stock Price & Dividends
Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US58506Q1094
Medpace Holdings, Inc. is a company that focuses on clinical research and offers services for drug and medical device development across North America, Europe, and Asia. They have a wide range of services that support the clinical development process from Phase I to Phase IV in different therapeutic areas.
In addition to providing clinical development services for the pharmaceutical, biotechnology, and medical device industries, Medpace Holdings, Inc. also offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Their services include project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance, new drug application submissions, and post-marketing clinical support services.
Established in 1992 and headquartered in Cincinnati, Ohio, Medpace Holdings, Inc. is committed to delivering comprehensive and high-quality research services to support the advancement of new drugs and medical devices. To learn more about Medpace Holdings, Inc., you can visit their website at https://www.medpace.com.
Drawdown (Underwater) Chart
MEDP Stock Overview
Market Cap in USD | 11,658m |
Sector | Healthcare |
Industry | Diagnostics & Research |
GiC SubIndustry | Life Sciences Tools & Services |
TER | 0.00% |
IPO / Inception | 2016-08-11 |
MEDP Stock Ratings
Growth 5y | 9.04 |
Fundamental | 77.6 |
Dividend | - |
Rel. Performance vs Sector | 6.16 |
Analysts | 3.75/5 |
Fair Price Momentum | 504.59 USD |
Fair Price DCF | 300.11 USD |
MEDP Dividends
Yield 12m | 0.00% |
Yield on Cost 5y | 0.00% |
Dividends CAGR 5y | 0.00% |
Payout Consistency | 0.0% |
MEDP Growth Ratios
Growth 12m | 97.83% |
Growth Correlation 12m | 78% |
Growth Correlation 3m | 24% |
CAGR 5y | 46.05% |
Sharpe Ratio 12m | 2.46 |
Alpha vs SP500 12m | 66.39 |
Beta vs SP500 5y weekly | 1.40 |
ValueRay RSI | 37.15 |
Volatility GJR Garch 1y | 38.78% |
Price / SMA 50 | -0.43% |
Price / SMA 200 | 30.34% |
Current Volume | 144.7k |
Average Volume 20d | 248.2k |
External Links for MEDP Stock
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X (Twitter) • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
As of April 28, 2024, the stock is trading at USD 395.93 with a total of 144,681 shares traded.
Over the past week, the price has changed by +6.43%, over one month by -1.69%, over three months by +32.79% and over the past year by +94.15%.
According to ValueRays Forecast Model, MEDP Medpace Holdings will be worth about 568.2 in April 2025. The stock is currently trading at 395.93. This means that the stock has a potential upside of +43.52%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 422.8 | 6.79 |
Analysts Target Price | 269.5 | -31.9 |
ValueRay Target Price | 568.2 | 43.5 |